In vivo imaging of nicotinic acetylcholine recptors in patients with Parkinson's disease
帕金森病患者烟碱乙酰胆碱受体的体内成像
基本信息
- 批准号:16591202
- 负责人:
- 金额:$ 2.24万
- 依托单位:
- 依托单位国家:日本
- 项目类别:Grant-in-Aid for Scientific Research (C)
- 财政年份:2004
- 资助国家:日本
- 起止时间:2004 至 2005
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
Neuronal nicotinic acetylcholine receptors (nAChRs) are widely distributed in the human brain. Recently, 5-iodo-3-(2S)-azetidinylmethoxy) pyridine (5IA) has been synthesized as a radioligand for imaging nAChRs with SPECT. The purpose of this study was to establish the quantitative measurements of nAChR binding by using 5IA SPECT and apply it to Parkinson's disorders.In the healthy volunteers, a 6-h dynamic SPECT acquisition was performed just after an I-123 5IA injection. Arterial blood samplings were done and pure 5IA concentrations were obtained by the TLC as input function. Two-compartment model (2C) and Logan plot were applied for kinetic analysis. Two scans were done in the smoking healthy volunteers, one was under smoking state and another was after 20-days smoke-free period. In the second, we performed 5IA SPECT studies in the patients with Parkinson's disease (PD).Good relationship was found between two distribution volumes (DVs) obtained by using 2C and Logan plot. DVs were th … More e highest in the thalamus, moderate in the pons, cerebellum, basal ganglia, lower in cerebral cortices. Good agreement was observed between DV values and results of autoradiographic experiments done in vitro for nAChR density in human brain. The DV during smoking were significantly lower than those under smoke-free state. The PD group showed a tendency for DV reduction in all brain regions and a statistically significant decrease in the brainstem and frontal cortex as compared with the control group. Although age, duration of disease, daily dose of levodopa, duration of PD medication use, and scores on the motor section of Unified Parkinson's Disease Rating Scale were not significantly correlated with DVs in any brain regions, high daily doses of dopamine agonist showed a significant negative correlation with DVs in the stratum, cerebellum, and temporal and parietal cortices.These findings suggest that patients with PD without dementia can show reductions in brain nAChRs, especially in the brainstem and frontal cortex. They also suggest that dopamine agonists can have a negative influence on the distribution of nAChRs. Our results also indicated that 5IA SPECT may become a useful method for the quantitative measurements for nAChRs in other neurodegenerative disorders. Less
神经元烟碱乙酰胆碱受体(nAChR)广泛分布于人脑中。最近,5-碘-3-(2S)-氮杂环丁烷甲氧基)吡啶(5IA)已被合成作为放射性配体与SPECT成像nAChR。为建立5IA SPECT定量测定nAChR结合的方法,并应用于帕金森病的研究,对健康志愿者注射I-123 5IA后立即进行6 h动态SPECT显像。进行动脉血取样,并通过TLC作为输入函数获得纯5IA浓度。采用二室模型(2C)和Logan图进行动力学分析。对吸烟的健康志愿者进行了两次扫描,一次是在吸烟状态下,另一次是在20天无烟期后。第二部分对帕金森病(PD)患者进行了5IA SPECT显像,用2C法和Logan法计算的分布容积(DV)之间有良好的相关性。DV是 ...更多信息 丘脑最高,脑桥、小脑、基底节中等,大脑皮质较低。在人脑中nAChR密度的DV值和体外放射自显影实验的结果之间观察到良好的一致性。吸烟状态下的DV显著低于无烟状态下的DV。与对照组相比,PD组显示所有脑区DV减少的趋势,脑干和额叶皮质的DV减少具有统计学意义。尽管年龄、疾病持续时间、左旋多巴的日剂量、PD药物使用的持续时间和统一帕金森病评定量表的运动部分的分数与任何脑区域中的DV没有显著相关性,但高日剂量的多巴胺激动剂显示出与小脑、小脑、小脑和小脑中的DV显著负相关性。这些发现表明,没有痴呆的PD患者可以显示大脑nAChR的减少,特别是在脑干和额叶皮层。他们还表明,多巴胺激动剂可能对nAChR的分布产生负面影响。我们的研究结果还表明,5IA SPECT可能成为一个有用的方法,定量测量nAChRs在其他神经退行性疾病。少
项目成果
期刊论文数量(26)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Regional cerebral bolld flow in Parkinson disease with nonpsychotic visual hallucinations.
帕金森病伴非精神病性视幻觉的局部脑血流。
- DOI:
- 发表时间:2005
- 期刊:
- 影响因子:0
- 作者:Oishi N;et al.
- 通讯作者:et al.
5-[I-123] Iodo-A-85380 : assessment of pharmacological safety, radiation dosimetry and SPECT imaging of brain nicotinic receptors in healthy subjects.
5-[I-123] Iodo-A-85380:健康受试者脑烟碱受体的药理学安全性、辐射剂量测定和 SPECT 成像评估。
- DOI:
- 发表时间:2004
- 期刊:
- 影响因子:0
- 作者:Ueda M;et al.
- 通讯作者:et al.
Regional cerebral blood flow in Parkinson disease with nonpsychotic visual hallucinations
- DOI:10.1212/01.wnl.0000187116.13370.e0
- 发表时间:2005-12-13
- 期刊:
- 影响因子:9.9
- 作者:Oishi, N;Udaka, F;Fukuyama, H
- 通讯作者:Fukuyama, H
Decrease in cortical benzodiazepine receptors in symptomatic patients with leukoaraiosis - A positron emission tomography study
- DOI:10.1161/01.str.0000122624.32167.e0
- 发表时间:2004-04-01
- 期刊:
- 影响因子:8.3
- 作者:Ihara, M;Tomimoto, H;Fukuyama, H
- 通讯作者:Fukuyama, H
nicotinic acetylcholine receptors imaging in the patients with dementia.
痴呆患者的烟碱乙酰胆碱受体成像。
- DOI:
- 发表时间:2006
- 期刊:
- 影响因子:0
- 作者:Washiyama K;他;Liu Y;Hashikawa K.
- 通讯作者:Hashikawa K.
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
HASHIKAWA Kazuo其他文献
HASHIKAWA Kazuo的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('HASHIKAWA Kazuo', 18)}}的其他基金
Quantification of the heterogeneity of cerebral blood flow SPECT in the patients with vascular dementia.
血管性痴呆患者脑血流 SPECT 异质性的量化。
- 批准号:
13670934 - 财政年份:2001
- 资助金额:
$ 2.24万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Optical Management of Blood Pressure in the hypertensive patients with cerebrovascular disease.-Split dose I-123 IMP SPECT Study-
高血压合并脑血管疾病患者血压的光学管理。-分剂量 I-123 IMP SPECT 研究-
- 批准号:
10670655 - 财政年份:1998
- 资助金额:
$ 2.24万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
相似海外基金
Development and Translation Mass Spectrometry Methods to Determine BioMarkers for Parkinson's Disease and Comorbidities
确定帕金森病和合并症生物标志物的质谱方法的开发和转化
- 批准号:
2907463 - 财政年份:2024
- 资助金额:
$ 2.24万 - 项目类别:
Studentship
Development of a predictive biomarker for Parkinson's disease
帕金森病预测生物标志物的开发
- 批准号:
MR/Y019415/1 - 财政年份:2024
- 资助金额:
$ 2.24万 - 项目类别:
Research Grant
Promoting Parkinson's disease trial participation in rural and coastal communities
促进农村和沿海社区参与帕金森病试验
- 批准号:
2898794 - 财政年份:2024
- 资助金额:
$ 2.24万 - 项目类别:
Studentship
Neurophysiological mechanism underlying freezing of gait in Parkinson's disease: transcutaneous spinal cord stimulation for gait disturbance
帕金森病步态冻结的神经生理机制:经皮脊髓刺激治疗步态障碍
- 批准号:
23K10409 - 财政年份:2023
- 资助金额:
$ 2.24万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Inhibition of cell-to-cell propagation of alpha-synuclein aggregation by glial cells and its involvement in neuropathology in Parkinson's disease.
神经胶质细胞抑制α-突触核蛋白聚集的细胞间传播及其参与帕金森病的神经病理学。
- 批准号:
23K06928 - 财政年份:2023
- 资助金额:
$ 2.24万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Propagation of a-synuclein in Parkinson's disease progress
α-突触核蛋白在帕金森病进展中的传播
- 批准号:
22KJ2095 - 财政年份:2023
- 资助金额:
$ 2.24万 - 项目类别:
Grant-in-Aid for JSPS Fellows
The Diagnostic and Prognostic Utility of Eye Tracking in Parkinson's Disease and Related Disorders
眼动追踪在帕金森病及相关疾病中的诊断和预后效用
- 批准号:
479285 - 财政年份:2023
- 资助金额:
$ 2.24万 - 项目类别:
Operating Grants
Drug-microbiome-host interactions in Parkinson's disease
帕金森病的药物-微生物组-宿主相互作用
- 批准号:
2881438 - 财政年份:2023
- 资助金额:
$ 2.24万 - 项目类别:
Studentship
MICA: How does the pedunculopone nucleus influence treatment responses in Parkinson's disease, and can it be targeted for new treatment strategies
MICA:脚核如何影响帕金森病的治疗反应,是否可以作为新治疗策略的目标
- 批准号:
MR/X005267/1 - 财政年份:2023
- 资助金额:
$ 2.24万 - 项目类别:
Research Grant
Ordering the disordered in Parkinson's disease to derive peptide inhibitors of alpha-synuclein toxicity
命令帕金森病患者衍生出α-突触核蛋白毒性的肽抑制剂
- 批准号:
2884235 - 财政年份:2023
- 资助金额:
$ 2.24万 - 项目类别:
Studentship